Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT07216846 · ClinicalTrials.gov registry record · NA
The Geriatric Emergency Department Pharmacologic Harm Prevention Project
A NA study of Fall and Polypharmacy, sponsored by Florida Atlantic University.
- Recruiting
- Registry status
- NA
- Development phase
- 1,000
- Enrollment target
- 1
- Study location
NCT07216846: Recruiting NA study of Fall and Polypharmacy, sponsored by Florida Atlantic University.
NCT07216846 is a NA study of Fall and Polypharmacy that is actively recruiting participants, run by Florida Atlantic University. The registered enrollment target is 1,000 participants, below the 1,255-participant average among 19 other Fall trials with a reported enrollment target (20% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT07216846, a NA study of Fall and Polypharmacy, is actively recruiting participants, sponsored by Florida Atlantic University.
- RECRUITING
- Registry status
- NA
- Development phase
- 1,000 participants
- Enrollment target
- 1
- Study location
Study Summary
The goal of this project is to determine whether pharmacogenomic testing (using participants' DNA) can help optimize medication prescribing and reduce side effects in older adults taking five or more medications. The main questions it aims to answer are: * Can DNA-based prescribing reduce medication-related side effects, especially falls and fall-related injuries? * Does providing pharmacogenomic results to primary care physicians improve medication safety compared with usual care? Researchers will compare two groups: 1. DNA Care Pathway: Physicians receive patients' DNA results to guide prescribing. 2. Emergency Department Care Pathway: Physicians provide usual care; DNA results are shared only after study completion. Participants will: * Provide a cheek swab sample for DNA analysis (1 minute). * Receive monthly follow-up phone calls for 6 months to track falls, injuries, medication changes, and side effects. * Complete a fall and medication calendar. * Allow researchers to review primary care physician medical records for study outcomes. Approximately 1,000 participants will take part, with follow-up lasting about 6-7 months.
Primary Outcome
Incidence of recurrent falls during 6-7 months of follow-up. Around the fourteenth day of the study and then once a month for the following six months, participants will receive a follow-up phone call to assess any falls that may have occurred. In addition, each participant will receive a calendar to record falls during the month. At six-month, the primary care physician medical records will be reviewed to check for any additional falls.
Conditions Studied
Interventions
- OTHER DNA care pathway
Study Locations (1)
Florida
- Delray Medical Center - Delray Beach
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 1,000 participants |
| Start Date | 2026-01-01 |
| Est. Completion | 2027-12-31 |
| Phase | NA |
What NCT07216846 shows while recruiting
NCT07216846 is an interventional study that assigns participants to a tested intervention. Its 1,000 participants enrollment target places it among the larger protocols in the corpus, below the 1,255-participant average among 19 other Fall trials with a reported enrollment target (20% lower).
The record links to 6 conditions, with Fall appearing as the primary indexed condition, and to 1 intervention - of which DNA care pathway is the first listed.
NCT07216846 reports a single indexed study location in Florida.
Frequently Asked Questions
What is clinical trial NCT07216846 about?
NCT07216846 is a clinical study titled "The Geriatric Emergency Department Pharmacologic Harm Prevention Project". The goal of this project is to determine whether pharmacogenomic testing (using participants' DNA) can help optimize medication prescribing and reduce side effects in older adults taking five or more medications. The main questions it aims to answer are: * Can DNA-based prescribing reduce medicati...
What is the current status of trial NCT07216846?
This trial is currently recruiting. It is a NA study. The enrollment target is 1,000 participants. The study started on 2026-01-01. Estimated completion is 2027-12-31.
What conditions does trial NCT07216846 study?
This clinical trial studies the following conditions: Fall, Polypharmacy, Adverse Drug Events, Pharmacogenomic Drug Interaction, Pharmacogenomic Testing.
What interventions are being tested in trial NCT07216846?
The interventions under investigation include: DNA care pathway (OTHER).
Who is sponsoring clinical trial NCT07216846?
This trial is sponsored by Florida Atlantic University, which has 27 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT07216846 being conducted?
This trial has 1 study location across Florida. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Fall
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT07216846's enrollment target sits among peer trials
1,000 2nd of 19 the highest of 19 other Fall trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Fall trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Optimizing a Technology-based Body and Mind Intervention
RECRUITING · NA
-
Comparison of Smartphone and Community-Based Delivery of the Otago Exercise Program for Fall Risk in Older Adults
RECRUITING · NA
-
Integrated Tele-Behavioral Activation and Fall Prevention for Low-income Homebound Seniors With Depression
RECRUITING · NA
-
Real-life Dual-Task Training
RECRUITING · NA
-
Exercise Program for Deaf Seniors to Increase Their Balance and Fitness
ACTIVE NOT RECRUITING · NA
-
COcoa Supplement and Multivitamin Outcomes Study: Effects on Falls and Physical Performance
ACTIVE NOT RECRUITING · NA
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT00018044 · 1,000 participants
Study of Mycobacterial Infections
- NCT01036581 · 1,000 participants · NA
Advanced Functional and Structural MRI Techniques for Neuropharmacological Imaging
- NCT01192048 · 1,000 participants
Genetics of Congenital Heart Disease
- NCT01553214 · 1,000 participants · Phase 4
Improving White Blood Cell Collection From Healthy Donors
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI